Post by
1998novl on Nov 09, 2020 8:13am
Vaccine
So Pfizer vaccine 90% effetive! Wow. Perhaps we see herd immunity a lot quicker than anticipated, thoughts?
Comment by
SPCEO1 on Nov 09, 2020 10:18am
As life gets back to normal, which is still quite a ways off, that should help the sales of Trogarzo very minimally and Egrifta to a larger extent. But the stock really should not be too impacted by that as the real catalysts for the stock at this point should be developments on the R&D front. Not that any of us would complain about improve sales though.
Comment by
Bucknelly21 on Nov 09, 2020 10:29am
Why would it.... not like this news helps any other stock!!! Lol
Comment by
qwerty22 on Nov 09, 2020 11:18am
also removes some uncertainty about recruitment for next years trials.
Comment by
scarlet1967 on Nov 09, 2020 11:52am
That is quite important as the company's valuation will be based on the R&D success going forward, if and when they get the nod from the agencies it will be business as usual in a COVID free world. In terms of timing it is also perfect as by the time they start the process the vaccine should have been distributed for a while some time in Q1/Q2 2021.